Autopsy report · NCT04487262

Timing for Removal of Chest Tubes in Adult Cardiac Surgery

“Safety interim analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 2 months before it stopped.
• 515 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Aarhus University Hospital Skejby

Sponsor type

University, hospital or other

Conditions

Heart Surgery; Chest Tube; Effusion Pleural; Pain, Postoperative

Interventions

Cardiac surgery

Participants

515

Sites

1

Countries

Denmark

Trials that died the same way

• A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)
  “Safety Issues” (70% match in meaning)
• Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
  “New Safety Information” (69% match in meaning)
• A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
  “Safety Review” (68% match in meaning)
• Atrial Pressure Electrophysiology Pilot Study
  “Interim evaluation of data after internal safety report from sponsor.” (67% match in meaning)
• Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.
  “Long term safety follow-up no longer required” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.